TY  - GEN
AU  - O'Toole,Aoibhlinn
AU  - Moss,Alan C
TI  - Optimizing Biologic Agents in Ulcerative Colitis and Crohn's Disease
SN  - 1534-312X
PY  - 2016///0322
KW  - Adalimumab
KW  - therapeutic use
KW  - Biological Factors
KW  - Colitis, Ulcerative
KW  - drug therapy
KW  - Crohn Disease
KW  - Drug Monitoring
KW  - methods
KW  - Drug Substitution
KW  - Evidence-Based Medicine
KW  - Humans
KW  - Infliximab
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1007/s11894-015-0453-1
ER  -